Precision Neuroscience IPO
Precision Neuroscience is developing ultra-thin brain-computer interfaces designed to be less invasive than traditional neural implants. Founded by a Neuralink co-founder, the company is working on technology to help patients with neurological conditions control external devices with their thoughts.
What We Know
Precision Neuroscience has not announced any IPO plans and continues to focus on developing its brain-computer interface technology. The company, founded by Benjamin Rapoport who previously co-founded Neuralink, is working on a different technical approach using ultra-thin arrays that could be less invasive than competing solutions. The company is still in relatively early stages compared to some competitors in the brain-computer interface space. As the neurotechnology sector continues to attract investor interest and achieve clinical progress, companies like Precision Neuroscience may become IPO candidates, but no timeline or plans have been disclosed.
Frequently Asked Questions
Has Precision Neuroscience had an IPO?
No, Precision Neuroscience has not had an IPO and remains a private company. The neurotechnology startup has not announced plans to go public.
When is the Precision Neuroscience IPO date?
Precision Neuroscience has not announced an IPO date or timeline. There are no confirmed details about when or if the company plans to go public. Sign up for alerts to stay informed.
How can I buy Precision Neuroscience stock?
Precision Neuroscience stock cannot be purchased as the company is private and not publicly traded. If the company goes public, shares would become available through brokers. Sign up for alerts to stay informed.
Stay Updated on the Precision Neuroscience IPO
Get real-time alerts when Precision Neuroscience files for an IPO, prices shares, or begins trading.
Get IPO Alerts